Plasmodium berghei: immunosuppression and hyperimmunoglobulinemia.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D002738:Chloroquine / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D006942:Hypergammaglobulinemia; D007108:Immune Tolerance; D007070:Immunoglobulin A / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007165:Immunosuppression Therapy; D008288:Malaria / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010659:Phenylhydrazines / Q000627:therapeutic use; D010950:Plasma Cells; D010962:Plasmodium berghei; D013154:Spleen / Q000473:pathology
D000941:Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010659:Phenylhydrazines; D002738:Chloroquine